Monsanto Roundup Lawsuit

Wednesday, April 30, 2008

GSK Australia - Clearly Behind the times

"Aropax corrects the chemical imbalance and so helps relieve the symptoms of depression."
http://www.gsk.com.au/products_prescription-medicines_detail.aspx?view=64

The Irish equivalent of the MHRA, the Irish Medical Board, recently banned GlaxoSmithKline from claiming that paroxetine corrects a chemical imbalance even in their patient information leaflets [HERE].

Should the Australian equivalent of the MHRA do the same or do Australians have different enzymes from Europeans?

In fact I am unsure whether or not this is the stance of the MHRA?

Is the chemical imbalance theory fact or merely a theory?

If indeed it is a theory .. and only a theory, what the hell are GSK Australia playing out by making such a false and misleading claim?, If indeed it is misleading and false?

I've wrote about this before.

Maybe an email to the TGA will help?

Fid

----- Original Message -----
From: fiddaman
To: TGA.Advertising@tga.gov.au
Sent: Wednesday, April 30, 2008 1:00 PM
Subject: GSK claim - False and misleading


Dear Sir/Madam,

I wish to complain strongly about the claims GSK Australia are making on their webpage. - http://www.gsk.com.au/products_prescription-medicines_detail.aspx?view=64

They claim that:

"Aropax corrects the chemical imbalance and so helps relieve the symptoms of depression."

This is false and misleading according to this paper from Plos Medicine. http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371%2Fjournal.pmed.0020392

I trust you will take this matter very seriously?

Sincerely

Mr Bob Fiddaman,
UK

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

By Bob Fiddaman

ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING

AVAILABLE FOR DOWNLOAD HERE


PAPERBACK COMING SOON
Post a Comment